There’s a New Bill of Rights for People With Alzheimer’s
Now, there is a bill of rights for people living with Alzheimer’s disease. It was drafted by the patient-founded nonprofit organization Voices of Alzheimer’s. …
Now, there is a bill of rights for people living with Alzheimer’s disease. It was drafted by the patient-founded nonprofit organization Voices of Alzheimer’s. …
The Food and Drug Administration has decided to postpone its decision on the approval of Eli Lilly’s candidate Alzheimer’s drug, donanemab. The delay has…
Neurologists and Alzheimer’s research experts explain the side effect known as ARIA — or brain bleeds — associated with the use of anti-amyloid monoclonal antibody…
If you or a loved one is going through the diagnostic process for Alzheimer’s, one of the terms you’re likely to hear quite a…
Biogen and Eisai’s monoclonal antibody drugs for Alzheimer’s — Aduhelm (now off the market) and Leqembi (fully approved by the FDA in 2023) —…
Biogen renounced ownership of their controversial anti-Alzheimer’s drug Aduhelm after years of dismal sales. The company is also halting an ongoing clinical trial set…
The process of finding new treatments for Alzheimer’s disease is one of trial and error — and every “failed” trial generates invaluable new data…
On July 6, 2023, the U.S. Food and Drug Administration fully approved the Alzheimer’s drug Leqembi (generic name lecanemab), a monoclonal antibody drug for…
I’ve always been a bit of a technology geek. I still have a few memories of sitting at my desk at the ACLU’s Washington…
As the proportion of older people in the population around the world increases, the prevalence of dementia will increase in turn. By 2030, it…
A few years ago, I listened to my doctors and grudgingly scheduled myself a colonoscopy – one of the most dreaded parts of hitting…
Alzheimer’s disease is responsible for 60 to 80 percent of all cases of dementia, and to date, most dementia research and treatments have focused…
Have you made that free flu shot appointment at your local pharmacy yet? The data shows that people who skip their flu shot had…
UPDATE: 3 March 2024, 8:14 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
It was 7:20 a.m. and Joel Braunstein, co-founder and CEO of C2N Diagnostics, was about to start his second meeting of the day. C2N…